Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: A historical cohort study based on laboratory and claims data from a national insurance provider

American Journal of Kidney Diseases

Volumn 58, Issue 3, 2011, Pages 398-408

  Neri, Luca ^a,b   Rocca Rey, Lisa A ^c   Lentine, Krista L ^a   Hinyard, Leslie J ^a   Pinsky, Brett ^d   Xiao, Huiling ^a   Dukes, Jonathan ^a   Schnitzler, Mark A ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c IRCCS MULTIMEDICA   (Italy)

^d Health Economics and Outcomes Research   (United States)

Author keywords

cardiovascular risk; chronic kidney disease; historical cohort; Serum uric acid

Indexed keywords

AGENTS AFFECTING METABOLISM; ANTIHYPERTENSIVE AGENT; CREATININE; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOURICEMIC AGENT; UNCLASSIFIED DRUG; URIC ACID;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BILLING AND CLAIMS; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMORBIDITY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; GOUT; HEART FAILURE; HEART INFARCTION; HISTORICAL RESEARCH; HUMAN; HYPERURICEMIA; ISCHEMIC HEART DISEASE; LABORATORY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL HEALTH INSURANCE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; PREDICTIVE VALUE; RENAL REPLACEMENT THERAPY; STROKE; URIC ACID BLOOD LEVEL;

ADULT; AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; COMORBIDITY; CREATININE; DATABASES, FACTUAL; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERURICEMIA; INCIDENCE; INSURANCE CARRIERS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; URIC ACID;

EID: 80051918279     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.04.025     Document Type: Article

References (51)

1. D.I. Feig, D.H. Kang, and R.J. Johnson Uric acid and cardiovascular risk N Engl J Med 359 2008 1811 1821
2. E.L. Schiffrin, M.L. Lipman, and J.F. Mann Chronic kidney disease: effects on the cardiovascular system Circulation 116 2007 85 97 (Pubitemid 47016250)
3. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, and C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 2004 1296 1305
4. B.F. Culleton, M.G. Larson, W.B. Kannel, and D. Levy Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study Ann Intern Med 131 1999 7 13 (Pubitemid 29310011)
5. D.H. Kang, T. Nakagawa, and L. Feng A role for uric acid in the progression of renal disease J Am Soc Nephrol 13 2002 2888 2897 (Pubitemid 35386908)
6. M. Mazzali, J. Hughes, and Y.G. Kim Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism Hypertension 38 2001 1101 1106 (Pubitemid 34252813)
7. M. Mazzali, J. Kanellis, and L. Han Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism Am J Physiol Renal Physiol 282 2002 F991 F997
8. L.G. Sanchez-Lozada, E. Tapia, and C. Avila-Casado Mild hyperuricemia induces glomerular hypertension in normal rats Am J Physiol Renal Physiol 283 2002 F1105 F1110
9. L.G. Sanchez-Lozada, E. Tapia, and J. Santamaria Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats Kidney Int 67 2005 237 247 (Pubitemid 40019245)
10. L.V. Franse, M. Pahor, and M. Di Bari Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP) J Hypertens 18 2000 1149 1154
11. J. Fang, and M.H. Alderman Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971-1992 National Health and Nutrition Examination Survey JAMA 283 2000 2404 2410 (Pubitemid 30257539)
12. J.T. Moriarity, A.R. Folsom, C. Iribarren, F.J. Nieto, and W.D. Rosamond Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study Ann Epidemiol 10 2000 136 143 (Pubitemid 30171270)
13. D.I. Feig, and R.J. Johnson Hyperuricemia in childhood primary hypertension Hypertension 42 2003 247 252 (Pubitemid 37093468)
14. L.K. Niskanen, D.E. Laaksonen, and K. Nyyssonen Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study Arch Intern Med 164 2004 1546 1551 (Pubitemid 38970476)
15. A.M. Strasak, C.C. Kelleher, and L.J. Brant Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study Int J Cardiol 125 2008 232 239
16. E. Krishnan, K. Svendsen, J.D. Neaton, G. Grandits, and L.H. Kuller Long-term cardiovascular mortality among middle-aged men with gout Arch Intern Med 168 2008 1104 1110 (Pubitemid 351749228)
17. P.W. De Leeuw, L. Thijs, and W.H. Birkenhager Prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the Syst-Eur trial J Am Soc Nephrol 13 2002 2213 2222 (Pubitemid 34925231)
18. S.P. Hsu, M.F. Pai, Y.S. Peng, C.K. Chiang, T.I. Ho, and K.Y. Hung Serum uric acid levels show a ′J-shaped′ association with all-cause mortality in haemodialysis patients Nephrol Dial Transplant 19 2004 457 462
19. M.E. Suliman, R.J. Johnson, and E. Garcia-Lopez J-shaped mortality relationship for uric acid in CKD Am J Kidney Dis 48 2006 761 771 (Pubitemid 44740052)
20. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 suppl 1 2002 S1 S266
21. M.D. Philipneri, L.A. Rocca Rey, and M.A. Schnitzler Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review Clin Exp Nephrol 12 2008 41 52
22. C. DeNavas-Walt, B.D. Proctor, and C. Hill Lee Income, poverty, and health insurance coverage in the United States: 2005 Obtained from US Census Bureau website http://www.census.gov/hhes/www/hlthins/index.html Accessed November 1, 2010
23. D.S. Freedman, D.F. Williamson, E.W. Gunter, and T. Byers Relation of serum uric acid to mortality and ischemic heart disease The NHANES I Epidemiologic Follow-up Study Am J Epidemiol 141 1995 637 644
24. K.R. Tuttle, R.A. Short, and R.J. Johnson Sex differences in uric acid and risk factors for coronary artery disease Am J Cardiol 87 2001 1411 1414 (Pubitemid 32523032)
25. K.M. Narayan, T.J. Thompson, and J.P. Boyle The use of population attributable risk to estimate the impact of prevention and early detection of type 2 diabetes on population-wide mortality risk in US males Health Care Manag Sci 2 1999 223 227
26. 2 Am J Kidney Dis 56 2010 486 495
27. S.G. Wannamethee, A.G. Shaper, and P.H. Whincup Serum urate and the risk of major coronary heart disease events Heart 78 1997 147 153 (Pubitemid 27404949)
28. M.H. Alderman, H. Cohen, S. Madhavan, and S. Kivlighn Serum uric acid and cardiovascular events in successfully treated hypertensive patients Hypertension 34 1999 144 150 (Pubitemid 29325733)
29. P. Verdecchia, G. Schillaci, G. Reboldi, F. Santeusanio, C. Porcellati, and P. Brunetti Relation between serum uric acid and risk of cardiovascular disease in essential hypertension The PIUMA Study Hypertension 36 2000 1072 1078
30. M. Tomita, S. Mizuno, and H. Yamanaka Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers J Epidemiol 10 2000 403 409
31. A.G. Ioachimescu, D.M. Brennan, B.M. Hoar, S.L. Hazen, and B.J. Hoogwerf Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study Arthritis Rheum 58 2008 623 630 (Pubitemid 351294901)
32. C.P. Wen, T.Y.D. Cheng, and H.T. Chan Is high serum uric acid a risk marker or a target for treatment? Examination of its independent effect in a large cohort with low cardiovascular risk Am J Kidney Dis 56 2010 273 288
33. M. Madero, M.J. Sarnak, and X. Wang Uric acid and long-term outcomes in CKD Am J Kidney Dis 53 5 2009 796 803
34. F. Barreto, D. Barreto, and S. Liabeuf Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients Clin J Am Soc Nephrol 4 10 2009 1551 1558
35. B. Satirapoj, M. Nata, and D. Utennam High levels of uric acid correlate with decline of glomerular filtration rate in chronic kidney disease J Med Assoc Thai 93 suppl 6 2010 S65 S70
36. N.D. Vaziri, R.W. Freel, and M. Hatch Effect of chronic experimental renal insufficiency on urate metabolism J Am Soc Nephrol 6 1995 1313 1317
37. J. Himmelfarb, P. Stenvinkel, T.A. Ikizler, and R.M. Hakim The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia Kidney Int 62 2002 1524 1538 (Pubitemid 35286260)
38. L.G. Sanchez-Lozada, T. Nakagawa, and D.H. Kang Hormonal and cytokine effects of uric acid Curr Opin Nephrol Hypertens 15 2006 30 33
39. R. Vanholder, S. Patel, and C.H. Hsu Effect of uric acid on plasma levels of 1,25(OH)2D in renal failure J Am Soc Nephrol 4 1993 1035 1038
40. J. Kanellis, S. Watanabe, and J.H. Li Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2 Hypertension 41 2003 1287 1293 (Pubitemid 36706079)
41. U.M. Khosla, S. Zharikov, and J.L. Finch Hyperuricemia induces endothelial dysfunction Kidney Int 67 2005 1739 1742 (Pubitemid 40577708)
42. D.B. Corry, P. Eslami, K. Yamamoto, M.D. Nyby, H. Makino, and M.L. Tuck Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system J Hypertens 26 2008 269 275
43. D.I. Feig, B. Soletsky, and R.J. Johnson Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial JAMA 300 2008 924 932
44. J. George, E. Carr, J. Davies, J.J. Belch, and A. Struthers High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid Circulation 114 2006 2508 2516 (Pubitemid 44901524)
45. W.S. Waring, J.A. McKnight, D.J. Webb, and S.R. Maxwell Lowering serum urate does not improve endothelial function in patients with type 2 diabetes Diabetologia 50 2007 2572 2579 (Pubitemid 350060638)
46. F. Khan, J. George, K. Wong, S. McSwiggan, A.D. Struthers, and J.J. Belch Allopurinol treatment reduces arterial wave reflection in stroke survivors Cardiovasc Ther 26 2008 247 252
47. F.J. Nieto, C. Iribarren, M.D. Gross, G.W. Comstock, and R.G. Cutler Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis 148 2000 131 139
48. N. Kuzkaya, N. Weissmann, D.G. Harrison, and S. Dikalov Interactions of peroxynitrite with uric acid in the presence of ascorbate and thiols: implications for uncoupling endothelial nitric oxide synthase Biochem Pharmacol 70 2005 343 354 (Pubitemid 40905106)
49. G. Bellomo, S. Venanzi, C. Verdura, P. Saronio, A. Esposito, and M. Timio Association of uric acid with change in kidney function in healthy normotensive individuals Am J Kidney Dis 56 2010 189 422
50. C. Frost Correcting for regression dilution bias: comparison of methods for a single predictor variable J R Stat Soc Series A 163 2000 173 189
51. J.H. O'Keefe, K.A. Bybee, and C.J. Lavie Alcohol and cardiovascular health: the razor-sharp double-edged sword J Am Coll Cardiol 50 2007 1009 1014 (Pubitemid 47348233)